Receptos Extends Gains On Safety Study, Analyst's Launch

By: via Benzinga
Receptos Inc (NASDAQ: RCPT) extended its gains Friday a day after it published positive safety results from a study of its colitis ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.